Journal List > J Cardiovasc Ultrasound > v.20(3) > 1018235

Yoon, Kim, Kim, Kim, Park, Park, Choi, Kim, Kim, and Cho: Left Atrial Mechanical Function and Stiffness in Patients with Paroxysmal Atrial Fibrillation

Abstract

Background

Abnormalities in the left atrial (LA) structure and function may develop in patients with paroxysmal atrial fibrillation (AF). We sought to determine the contribution of LA mechanical function, including LA stiffness, to AF by comparing patients with paroxysmal AF with normal control subjects, and to evaluate whether LA mechanical function and stiffness are related with the structural changes of LA.

Methods

Sixty-four paroxysmal AF patients (57 ± 13 years, 59% male) were studied, using a speckle tracking echocardiography, and were compared with 34 age-, gender-, and left ventricular (LV) mass-matched controls (53 ± 14 years, 61% male). LA volume indices, expansion index for reservoir function, active emptying fraction for contractile function, mitral annular velocities, and global longitudinal LA strain were measured. The ratio of E/e' to LA strain was used as an index of LA stiffness.

Results

Patients with paroxysmal AF had similar LV volume indices, ejection fraction, and diastolic function, when compared with that of the normal controls. However, paroxysmal AF patients showed increased LA volume indices and decreased LA reservoir function, but similar contractile function. LA stiffness was increased in patients with paroxysmal AF than in the control subjects (0.40 ± 0.25 vs. 0.29 ± 0.10, p = 0.002), and was related with LA volume indices and reservoir function.

Conclusion

Patients with paroxysmal AF have decreased LA reservoir function and increased stiffness, in comparison with that of the control subjects. LA stiffness was significantly related with LA volume indices and reservoir function. LA stiffness can be used for the assessment of LA function in patients with paroxysmal AF.

Introduction

Atrial fibrillation (AF) is the most frequently detected arrhythmia in the clinical setting, and is associated with increased cardiovascular risk.1)2) AF is a progressive condition that begins with hemodynamic and/or structural changes in the left atrium (LA) and evolves through the paroxysmal and persistent stage.3) Better understanding of LA structure and function could lead to improvements in our ability to predict the risk of developing AF and the response to treatment in patients with this arrhythmia. LA enlargement has been widely related to AF, both in patients with chronic AF and in those with paroxysmal AF.4-6) Over the past decade, there has been increasing interest in the noninvasive evaluation of LA size and mechanical function. LA function can be estimated by two-dimensional echocardiography, Doppler analysis of transmitral flow, and tissue Doppler assessment of LA myocardial velocities. Speckle tracking echocardiography allows the quantification of LA function, and recently, noninvasive estimate of LA strain by speckle tracking has been proposed.7) Several studies have shown that LA stiffness increases with atrial remodeling and reflects a deteriorated reservoir function.7)8) However, to date, little is known with regard to the change of LA mechanical function, including LA stiffness, in patients with AF. In this study, we tried to determine the contribution of LA mechanical function, including LA stiffness, to AF by comparing the paroxysmal AF patients with normal control subjects, and to evaluate whether LA mechanical function and stiffness are related with structural changes of LA.

Methods

Study population

We conducted a multicenter, prospective, case-control study. The study population included 64 patients [mean age, 57 ± 13 years; male, 59%; mean left ventricular (LV) mass index, 88 ± 21 g/m2] with paroxysmal AF who underwent echocardiography for the evaluation of cardiac structure and function, between June 2006 and October 2007. Inclusion criteria were as follows; 1) age older than 18 years, 2) recent onset and documented AF on an electrocardiogram or Holter recording in the previous 2 months, and 3) sinus rhythm at the time of the echocardiographic examination. Patients were excluded from the study if any of the following were present; 1) prior history of AF, 2) LV ejection fraction < 50%, 3) history of ischemic heart disease, 4) dyspnea of New York Heart Association functional class ≥ II, 5) valvular stenosis or regurgitation ≥ moderate, and 6) hyperthyroidism, acute illness, post-operative status. Thirty six healthy subjects with similar age, gender, and LV mass index distribution (mean age, 53 ± 14 years; male, 61%; mean LV mass index, 86 ± 18 g/m2) were randomly selected from the subjects who volunteered for general routine health evaluation and underwent echocardiography. None of the controls had any cardiovascular or systemic disease and had sinus rhythm. The institutional review board approved the study protocol.

Transthoracic echocardiography

A Vivid 7 ultrasound system (GE Vingmed Ultrasound, Horten, Norway) was used for the transthoracic echocardiographic examination. All images and measurements were acquired from the standard views, according to the guidelines of the American Society of Echocardiography9-11) and were digitally stored for offline analysis. In the parasternal long-axis views, LA maximum anterior-posterior (A-P) diameter was measured. In the apical 4-chamber view, LV end-diastolic and end-systolic volumes were measured and LV ejection fraction was calculated by the Simpson method. In the same view, LA superior-inferior (S-I) diameter was measured from the mitral annular plane to the posterior wall of the LA, and velocity time intergral of A wave (VTIA) was measured. Pulsed-wave Doppler at the tip of mitral valve leaflets allowed us to measure the early (E) and late (A) diastolic filling velocities, E/A ratio, and E deceleration time. The LV tissue velocity (e', a', s') were measured by tissue Doppler imaging of the medial mitral annulus and E/e' was calculated. From the apical 4- and 2-chamber view, the following LA volumes were measured using a biplane area-length method, and were indexed to body surface area: maximum volume (before mitral valve opening), pre-A volume (before atrial contraction), and minimum volume (after atrial contraction). LA reservoir function was estimated by the LA expansion index (%), computed as [(LA maximum volume - minimum volume) / minimum volume] × 100%. LA contractile function was estimated by the LA active emptying fraction (%), computed as [(LA pre-A volume - minimum volume) / pre-A volume] × 100%. LA ejection force (kdynes.cm/m2) was calculated according to the modified Manning method as (0.5 × ρ × LA active emptying volume index × A2) / VTIA, where ρ is blood density of 1.06 g/cm3, A is peak late diastolic transmitral flow velocity (cm/sec), and VTIA is late diastolic transmitral flow velocity time integral (cm).12) LA kinetic energy (kdynes/m2) was defined as 0.5 × ρ × LA active emptying volume index × A2.
The global systolic LA myocardial strain was measured by 2-dimensional speckle tracking echocardiography.8) Gray scale image of apical 4-chamber views was obtained with the frame rates of 50-80 Hz. Recordings were processed with acoustictracking software (EchoPAC, GE Healthcare, Horten, Norway), allowing off-line semi-automated speckle-based strain analyses. Briefly, the lines were manually traced, along the LA endocardium at the time of end-systolic phase. An additional epicardial line was automatically generated by software, which created a region of interest (ROI). After manually adjusting the ROI shape, the global peak LA strain during the whole cardiac cycle was calculated.13)14) In this study, to derive a noninvasive dimensionless parameter, the ratio of E/e' to LA peak strain was used to estimate the LA stiffness (Stiffnessstrain).7)8) We also estimated LA stiffness as the ratio of E/e' to LA filling volume (Stiffnessvol).

Statistical analyses

Continuous variables are expressed as the means and standard deviations; categorical variables are expressed as proportions. The Student t-test was used to test for the differences in normally distributed continuous variables, and the Wilcoxon rank sum test was used for comparisons involving the variables that were not normally distributed. Categorical variables were compared with the χ2 test or Fisher exact test as appropriate. A two-sided p-value of less than 0.05 was considered to represent a statistically significant difference. The correlation between LA stiffness and LA volume indices and mechanical function indices were evaluated using Pearson's correlation coefficient (PCC) and Spearman's rank correlation coefficient (SCC).

Results

The baseline clinical and echocardiographic characteristics of 64 patients with paroxysmal AF and 36 normal control subjects are summarized in Table 1. There was no significant difference between the paroxysmal AF patients and normal control subjects, with respect to age, gender, heart rate, and body surface area (Table 1). Although LA A-P diameter was not significantly different between the two groups (3.7 ± 0.6 vs. 3.5 ± 0.5, p = 0.207), S-I diameter was increased in patients with paroxysmal AF, compared to the normal control subjects (5.2 ± 0.8 vs. 4.8 ± 0.5, p = 0.002). LA volumes were also significantly larger in the paroxysmal AF patients than in the normal control subjects (minimal volume index, 16.6 ± 8.8 vs. 10.6 ± 4.6, p < 0.001; pre-A volume index, 22.3 ± 9.9 vs. 15.9 ± 6.5, p = 0.001; maximal volume index, 33.2 ± 11.4 vs. 26.7 ± 8.8, p = 0.004). Whereas, there was no significant differences in LV volume and mass indices, transmitral flow velocities and annular tissue velocities between the two groups (Table 1).
Table 2 describes the LA mechanical function in patients with paroxysmal AF and in the normal control subjects. The reservoir function, as estimated by LA expansion index, was significantly decreased in patients with paroxysmal AF, compared to that of the normal control subjects (118.1 ± 50.5 vs. 164.5 ± 54.4, p < 0.001). Whereas, decreased contractile function in patients with paroxysmal AF, as estimated by LA active emptying fraction, did not reach statistical significance (26.5 ± 12.8 vs. 31.7 ± 13.7, p = 0.056). There was no significant difference in LA energy, including kinetic energy (7.7 ± 7.6 vs. 6.6 ± 5.2, p = 0.449) and ejection force (1.1 ± 0.8 vs. 1.0 ± 0.7, p = 0.540) between the two groups. Paroxysmal AF patients showed lower global LA strain (27.3 ± 7.2 vs. 32.6 ± 7.0, p = 0.001) and higher LA stiffnessstrain (0.41 ± 0.24 vs. 0.29 ± 0.10, p = 0.001), compared to normal control subjects. However, when we estimate LA stiffness, using LA filling volume, LA stiffnessvol was not significantly different between two groups (0.68 ± 0.38 vs. 0.63 ± 0.26, p = 0.543).
Fig. 1 illustrated correlation between LA stiffnessstrain and LA volume indices. In the overall study population, the LA stiffnessstrain was strongly correlated with LA minimal (PCC = 0.702, p < 0.001; SCC = 0.467, p < 0.001), pre-A (PCC = 0.604, p < 0.001; SCC = 0.410, p < 0.001), and maximal volume indices (PCC = 0.523, p < 0.001; SCC = 0.388, p < 0.001) (Fig. 1). Fig. 2 illustrated correlation between LA stiffnessstrain and LA mechanical function indices. LA expansion index showed a negative correlation with LA stiffnessstrain (PCC = -0.484, p < 0.001; SCC = -0.429, p < 0.001) (Fig. 2A). LA active emptying fraction also showed a negative correlation with LA stiffnessstrain (PCC = -0.357, p < 0.001; SCC = -0.298, p = 0.003) (Fig. 2B). LA kinetic energy showed a weak correlation with LA stiffnessstrain (PCC = 0.255, p = 0.011; SCC = 0.201, p = 0.048), but LA ejection force did not show a significant correlation with LA stiffnessstrain (PCC = 0.085, p = 0.451; SCC = 0.086, p = 0.445) (Fig. 2C and D).

Discussion

The main findings of our study are that patients with paroxysmal AF showed a decreased reservoir function, rather than contractile function, and increased stiffness compared to the control subjects. LA stiffness was strongly correlated with LA volume indices and moderately correlated with atrial reservoir and contractile function. Paroxysmal AF may constitute a good model to study. If there is any anatomical or functional substrate in these patients with apparently normal hearts, those changes may promote the development of persistent or permanent AF. The importance of atrial enlargement in the development of AF is well-known.4-6) Sitges et al.6) found that LA enlargement was observed already in patients with paroxysmal AF. In this study, maximal LA dimensions, area and volume are significantly larger in patients with AF, when compared with the healthy volunteers without AF. Our results are in accordance with their findings on LA enlargement. Not only LA maximal volume, but also pre-A and minimal volumes were increased in the paroxysmal AF patients.
To date, little is known in regard to the role of LA function in the development of AF. In the current study, we found that LA reservoir function, as estimated by LA expansion index, was significantly decreased in patients with paroxysmal AF, compared to that of the normal control subjects. However, the difference in LA contractile function, as estimated by LA active emptying fraction, between the two groups did not reach a level of statistical significance. Although the role of LA mechanical function in the progression of AF was not examined in this investigation, a previous prospective study has shown that reduced LA reservoir function, as estimated by LA total emptying fraction, was a robust predictor of first AF or atrial flutter, which was superior and incremental to the maximum LA volume.15)
Recently, strain analyses with two-dimensional speckle tracking echocardiography have been applied to the LA.13)14) LA myocardial strain has been confirmed as a reliable index that represents the magnitude of atrial deformation.16) LA strain during LV systole indicates the LA reservoir function, and lower measurement value of it suggests a deteriorated LA function and progression of LA remodeling.8) In a previous study by Henein et al.,17) global LA strain and strain rate were significantly reduced in patients with paroxysmal AF, compared with the normal control subjects. We also found the decreased global LA strain in the paroxysmal AF patients. In a previous study by Kurt et al.,7) the use of LA strain, with LA pressure to estimate LA stiffness, has been reported. The authors also suggested the noninvasive estimation of LA stiffness by using the E/e' ratio in conjunction with LA strain. In the study, noninvasively measured LA stiffness, as well as invasively measured LA stiffness, were increased in patients with diastolic heart failure. In the current study, we found that the noninvasive estimate of LA stiffness was significantly increased in patients with paroxysmal AF, compared to those without AF. In addition, LA stiffness was correlated with LA volume indices and reservoir function.
This study has several limitations. First, despite the compared groups of the paroxysmal AF patients and healthy controls had similar distribution of age, gender, and LV mass index, they were not strictly matched. Therefore, difference in LA size and function could be partially influenced by age, which was slightly older (mean difference, 4 years), although not statistically significant, among patients with paroxysmal AF. However, the absence of any significant difference in LV diastolic function parameters suggests that this slight difference in age may not play a role in the large size and decreased mechanical function of LA in the AF group. Second, we compared paroxysmal AF patients only with the normal control subjects. Absence of the persistent/permanent AF group did not allow the evaluation of LA mechanical function, according to the progression of AF to chronic stage. In addition, this is the cross-sectional study; thus, we were not able to determine whether LA mechanical function including LA stiffness can predict the progression to chronic AF. Further study is required to evaluate the predictive value of LA stiffness or other mechanical function for the progression of AF.
In conclusion, patients with paroxysmal AF have decreased LA reservoir function and increased stiffness in comparison with the control subjects. LA stiffness was significantly related with LA volume indices and reservoir function. Noninvasively measured LA stiffness is expected to be used for the assessment of LA function in patients, but the role of LA stiffness in the progression of AF was remained to be proven.

Figures and Tables

Fig. 1
Correlation of left atrial stiffness and minimal (A), pre-A (B), and maximal (C) left atrial volume indices. The numbers in parenthesis indicate the p-values of corresponding coefficients. LA: left atrial, LAVI: left atrial volume indices, PCC: Pearson's correlation coefficient, SCC: Spearman's rank correlation coefficient.
jcu-20-140-g001
Fig. 2
Correlation of left atrial stiffness and left atrial expansion index (A), active emptying fraction (B), kinetic energy (C), and ejection force (D). The numbers in parenthesis indicate the p-values of corresponding coefficients. LA: left atrial, PCC: Pearson's correlation coefficient, SCC: Spearman's rank correlation coefficient.
jcu-20-140-g002
Table 1
Clinical and echocardiographic characteristics in patients with paroxysmal atrial fibrillation and in normal control subjects
jcu-20-140-i001

AF: atrial fibrillation, EDV: end-diastolic volume, ESV: end-systolic volume, E: peak early diastolic filling velocity, A: peak late diastolic filling velocity, s': peak early systolic velocity of the medial mitral annulus, e': peak early diastolic velocity of the medial mitral annulus, a': peak late diastolic velocity of the medial mitral annulus

Table 2
Left atrial mechanical function in patients with paroxysmal atrial fibrillation and in normal control subjects
jcu-20-140-i002

AF: atrial fibrillation, LA: left atrium

Acknowledgements

This study was supported by an Industry-Academy grant of Korean Society of Echocardiography (2008, Cho GY).

References

1. Vidaillet H, Granada JF, Chyou PH, Maassen K, Ortiz M, Pulido JN, Sharma P, Smith PN, Hayes J. A population-based study of mortality among patients with atrial fibrillation or flutter. Am J Med. 2002. 113:365–370.
crossref
2. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med. 2002. 113:359–364.
crossref
3. Kuppahally SS, Akoum N, Burgon NS, Badger TJ, Kholmovski EG, Vijayakumar S, Rao SN, Blauer J, Fish EN, Dibella EV, Macleod RS, McGann C, Litwin SE, Marrouche NF. Left atrial strain and strain rate in patients with paroxysmal and persistent atrial fibrillation: relationship to left atrial structural remodeling detected by delayed-enhancement MRI. Circ Cardiovasc Imaging. 2010. 3:231–239.
crossref
4. Dittrich HC, Pearce LA, Asinger RW, McBride R, Webel R, Zabalgoitia M, Pennock GD, Safford RE, Rothbart RM, Halperin JL, Hart RG. Left atrial diameter in nonvalvular atrial fibrillation: an echocardiographic study. Stroke Prevention in Atrial Fibrillation Investigators. Am Heart J. 1999. 137:494–499.
crossref
5. Parkash R, Green MS, Kerr CR, Connolly SJ, Klein GJ, Sheldon R, Talajic M, Dorian P, Humphries KH. Canadian Registry of Atrial Fibrillation. The association of left atrial size and occurrence of atrial fibrillation: a prospective cohort study from the Canadian Registry of Atrial Fibrillation. Am Heart J. 2004. 148:649–654.
crossref
6. Sitges M, Teijeira VA, Scalise A, Vidal B, Tamborero D, Collvinent B, Rivera S, Molina I, Azqueta M, Paré C, Brugada J, Mont L. Is there an anatomical substrate for idiopathic paroxysmal atrial fibrillation? A case-control echocardiographic study. Europace. 2007. 9:294–298.
crossref
7. Kurt M, Wang J, Torre-Amione G, Nagueh SF. Left atrial function in diastolic heart failure. Circ Cardiovasc Imaging. 2009. 2:10–15.
crossref
8. Machino-Ohtsuka T, Seo Y, Tada H, Ishizu T, Machino T, Yamasaki H, Igarashi M, Xu D, Sekiguchi Y, Aonuma K. Left atrial stiffness relates to left ventricular diastolic dysfunction and recurrence after pulmonary vein isolation for atrial fibrillation. J Cardiovasc Electrophysiol. 2011. 22:999–1006.
crossref
9. Cheitlin MD, Alpert JS, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davidson TW, Davis JL, Douglas PS, Gillam LD. ACC/AHA Guidelines for the Clinical Application of Echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardiography. Circulation. 1997. 95:1686–1744.
crossref
10. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ. Chamber Quantification Writing Group. American Society of Echocardiography's Guidelines and Standards Committee. European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005. 18:1440–1463.
crossref
11. Quiñones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA. Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr. 2002. 15:167–184.
crossref
12. Triposkiadis F, Harbas C, Sitafidis G, Skoularigis J, Demopoulos V, Kelepeshis G. Echocardiographic assessment of left atrial ejection force and kinetic energy in chronic heart failure. Int J Cardiovasc Imaging. 2008. 24:15–22.
crossref
13. D'Andrea A, Caso P, Romano S, Scarafile R, Riegler L, Salerno G, Limongelli G, Di Salvo G, Calabrò P, Del Viscovo L, Romano G, Maiello C, Santangelo L, Severino S, Cuomo S, Cotrufo M, Calabrò R. Different effects of cardiac resynchronization therapy on left atrial function in patients with either idiopathic or ischaemic dilated cardiomyopathy: a two-dimensional speckle strain study. Eur Heart J. 2007. 28:2738–2748.
14. Hwang HJ, Choi EY, Rhee SJ, Joung B, Lee BH, Lee SH, Kim J, Lee MH, Jang Y, Chung N, Kim SS. Left atrial strain as predictor of successful outcomes in catheter ablation for atrial fibrillation: a two-dimensional myocardial imaging study. J Interv Card Electrophysiol. 2009. 26:127–132.
crossref
15. Abhayaratna WP, Fatema K, Barnes ME, Seward JB, Gersh BJ, Bailey KR, Casaclang-Verzosa G, Tsang TS. Left atrial reservoir function as a potent marker for first atrial fibrillation or flutter in persons > or = 65 years of age. Am J Cardiol. 2008. 101:1626–1629.
crossref
16. Di Salvo G, Caso P, Lo Piccolo R, Fusco A, Martiniello AR, Russo MG, D'Onofrio A, Severino S, Calabró P, Pacileo G, Mininni N, Calabró R. Atrial myocardial deformation properties predict maintenance of sinus rhythm after external cardioversion of recent-onset lone atrial fibrillation: a color Doppler myocardial imaging and transthoracic and transesophageal echocardiographic study. Circulation. 2005. 112:387–395.
crossref
17. Henein M, Zhao Y, Henein MY, Lindqvist P. Disturbed left atrial mechanical function in paroxysmal atrial fibrillation: a speckle tracking study. Int J Cardiol. 2012. 155:437–441.
crossref
TOOLS
Similar articles